Jay Flatley, the CEO of Illumina, told the UK's Times that by 2019, the genome sequencing of newborns will be routine and that in three to four years a genome sequence should be available for less than $1,000. "The limitations are sociological; when and where people think it can be applied, the concerns people have about misinformation and the background ethics questions," Flatley says. At the Guardian, Ian Sample says the prospect is intriguing though he wonders if what people hear from their primary care doctors (don't drink too much, eat right, and exercise) would change.
Cheap and Routine
Feb 11, 2009